Question 1

Who owns PTGX?

Accepted Answer

PROTAGONIST THERAPEUTICS INC (PTGX) is held by 158 institutional investors that disclose positions via SEC 13F filings. The largest disclosed holder is BlackRock, Inc. as of Q1 2026.

Question 2

Are institutions buying or selling PTGX?

Accepted Answer

In Q1 2026, 91 institutions opened or increased positions in PROTAGONIST THERAPEUTICS INC while 68 reduced or exited — a net buying quarter.

Question 3

What is the Smart Money Verdict on PTGX?

Accepted Answer

HoldingsIntel scores PROTAGONIST THERAPEUTICS INC across four independent sources (institutional 13F activity, insider trades, activist filings, and congressional trades) — with 4 of the 4 carrying data for PTGX. In Q1 2026, the institutional leg showed net inflows: 91 buying versus 68 selling.

Question 4

How many hedge funds hold PTGX?

Accepted Answer

158 institutional investors report holding PROTAGONIST THERAPEUTICS INC (PTGX) as of Q1 2026, based on SEC 13F filings.

Question 5

Is institutional money flowing into PTGX?

Accepted Answer

As of Q1 2026, tracked institutions in PROTAGONIST THERAPEUTICS INC show 91 buyers versus 68 sellers — net inflows.

Question 6

Are Congress members and hedge funds both buying PTGX?

Accepted Answer

Yes — in the latest quarter, 1 members of Congress and 91 institutional investors bought PROTAGONIST THERAPEUTICS INC. HoldingsIntel cross-checks STOCK Act disclosures against 13F filings to surface these overlaps.

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
BlackRock, Inc.	Increased	9.8M(+0.7%)	$1B	0.0%	+225.25%	32
FARALLON CAPITAL MANAGEMENT, L.L.C.	Increased	6.3M(+3.3%)	$669.2M	3.8%	+506.77%	60
UBS Group AG	Increased	5.2M(+86.9%)	$545.7M	0.1%	+71.02%	49
RTW INVESTMENTS, LP	Unchanged	5.1M	$533.2M	5.3%	+439.60%	0
WELLINGTON MANAGEMENT GROUP LLP	Increased	3.6M(+13.5%)	$379.4M	0.1%	+91.12%	35
STATE STREET CORP	Decreased	3.1M(-2.6%)	$328.5M	0.0%	+267.72%	0
Janus Henderson Group Ltd.	Increased	2.9M(+9.1%)	$304.9M	0.1%	+69.62%	40
Invesco Ltd.	Increased	2.2M(+38.1%)	$228.2M	0.0%	+85.65%	40
GEODE CAPITAL MANAGEMENT, LLC	Increased	1.7M(+14.9%)	$176M	0.0%	+295.31%	35
PRICE T ROWE ASSOCIATES INC /MD/	Increased	1.7M(+18.9%)	$175.5M	0.0%	+153.18%	36
CITADEL ADVISORS LLC	Increased	1.6M(+37.7%)	$163.6M	0.0%	+55.50%	40
Woodline Partners LP	Increased	1.4M(+0.4%)	$149.1M	0.6%	+174.10%	43
BANK OF AMERICA CORP /DE/	Increased	1.3M(+49.3%)	$136.5M	0.0%	+103.27%	42
JENNISON ASSOCIATES LLC	Increased	1.1M(+223.7%)	$113M	0.1%	+45.94%	48
MORGAN STANLEY	Increased	1M(+15.8%)	$107.3M	0.0%	+131.23%	35
Hood River Capital Management LLC	New	829,285	$87.4M	0.9%	+43.94%	58
GOLDMAN SACHS GROUP INC	Decreased	778,945(-19.0%)	$82.1M	0.0%	+154.21%	0
DRIEHAUS CAPITAL MANAGEMENT LLC	Decreased	720,928(-34.4%)	$76M	0.6%	+148.43%	0
FMR LLC	Increased	661,997(+22.6%)	$69.8M	0.0%	+154.13%	36
MWMARSHALL WACE, LLP	Decreased	628,075(-38.7%)	$66.2M	0.1%	+101.75%	0

PROTAGONIST THERAPEUTICS INC

Smart Money Verdict

Who's Trading

Continue exploring

Other Healthcare stocks held by institutions

PROTAGONIST THERAPEUTICS INC

Smart Money Verdict

Who's Trading

Top Holders

Continue exploring

Other Healthcare stocks held by institutions